Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Students become entrepreneurs through Vanderbilt's IMPACT course

    ... course was highly interactive and hands-on, with substantial time for discussion and student presentations, and a number of experienced ...

    steelmk - 12/16/2016 - 1:30pm

  2. Vanderbilt Licensee gets acquired by Agilent Technologies

    ... iLab’s offerings, customers can easily and accurately book time in shared facilities to bill and invoice for projects, to manage studies, ...

    steelmk - 12/09/2016 - 2:56pm

  3. MTAShare now used for incoming MTAs

    ... by REDCap, the system has substantially reduced the average time for processing standard MTAs. CTTC would be pleased to assist research ...

    machinm - 10/02/2015 - 10:43am

  4. Oxygen-Tolerant Probiotic Therapy for Intestinal Inflammatory Diseases

    ... Therapeutics Field of Use: Gastrointestinal ...

    cttc_admin - 12/02/2025 - 1:04pm

  5. Vanderbilt collaborates with Boehringer Ingelheim for difficult-to-treat cancers

    ... made by Professor Fesik’s laboratory, we believe the time is now right to step up research efforts to develop novel cancer ...

    steelmk - 03/10/2017 - 10:58am

  6. Vanderbilt students compete in TechVenture Challenge

    ... organizers, sponsors, and mentors who contributed their time and work to this year’s TechVenture Challenge.  ...

    steelmk - 02/21/2019 - 9:51am

  7. Vanderbilt signs license agreement with student startup Path Ex

    05/11/2018 Vanderbilt University signed a license agreement ... sepsis. Sepsis is a major clinical problem, affecting over 1 million Americans per year and accounting for at least 250,000 deaths ... tests currently used to identify the specific bacteria take time to complete. The PATH EX product filters such bacteria out of the blood ...

    steelmk - 05/14/2018 - 8:32am

  8. Early effort to thwart chikungunya infection shows positive results

    ... this week announced positive results from a Phase 1 clinical study in healthy adults of a  new approach  to combat the ... in the current study. “This study shows for the first time the ability to generate therapeutic levels of a complex protein in humans ...

    sommers - 09/27/2019 - 9:55am

  9. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors ...

    steelmk - 10/02/2015 - 10:45am

  10. Skin diseases study uses crowdsourcing to gather data

    ... research, filed away in hospitals and clinics, but “the time and expense involved in having experts endlessly pore over these images is ...

    sommers - 02/27/2019 - 2:02pm